Myardiny_Toe Posted - 1 week ago

$OLMA

Newyorkerman Posted - 1 week ago

$OLMA BOUT TO PISS ROCKET TO $16

Paul_Volcker Posted - 1 week ago

$OLMA As long as the CPI doesn't come out too strong tomorrow I think this thing should keep moving in the right direction.

Stock_Titan Posted - 1 week ago

$OLMA Olema Oncology to Participate in Canaccord Genuity 2024 Horizons in Oncology Virtual Conference https://www.stocktitan.net/news/OLMA/olema-oncology-to-participate-in-canaccord-genuity-2024-horizons-in-yq6uasd16ut9.html

Myardiny_Toe Posted - 1 week ago

$OLMA big drop coming

mtomasini Posted - 1 week ago

$OLMA

Myardiny_Toe Posted - 1 week ago

$OLMA https://www.theguardian.com/business/andrew-clark-on-america/2009/jul/14/goldmansachs-banks Here comes $1.00

Myardiny_Toe Posted - 1 week ago

$OLMA new price target. Headed for a crash. Goldman sachs are blood sucking shorts 😁

BullyJoe711 Posted - 1 week ago

$CDTX since you all like crappy stocks. Go buy $OLMA and $OCGN

Stock_Titan Posted - 2 weeks ago

$OLMA Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/OLMA/olema-oncology-reports-inducement-grants-under-nasdaq-listing-rule-pcdwec28oxnv.html

erevnon Posted - 2 weeks ago

Goldman Sachs initiates coverage on Olema Pharmaceuticals $OLMA at Buy and a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

BillyBarue Posted - 2 weeks ago

$OLMA 📈 $SPY

DonCorleone77 Posted - 2 weeks ago

$OLMA Olema Oncology initiated with a Buy at Goldman Sachs Goldman Sachs initiated coverage of Olema Oncology with a Buy rating and $24 price target. The company's lead asset, palazestrant is being developed for advanced/metastatic ER+/HER2- breast cancer with total addressable market of 200,000 patients in the U.S. and Europe, the analyst tells investors in a research note. The firm sees "best-in-class potential" in a large ER+/HER2- breast cancer market and the possibility of Olema securing a biopharma partnership deal that could bring additional value to the stock.

insiderbuyingselling Posted - 03/29/24

$OLMA new insider selling: 20000 shares. http://insiderbuyingselling.com/?t=OLMA

Paul_Volcker Posted - 03/25/24

$OLMA This thing is due for a bounce

StockInvest_us Posted - 03/22/24

Signal alert: $OLMA - Oversold Trend Short (Undervalued) https://stockinvest.us/l/FbweVerATp

StockInvest_us Posted - 03/20/24

Signal alert: $OLMA - Oversold Trend Short (Undervalued) https://stockinvest.us/l/zk8Abav7f9

Hawker41 Posted - 03/20/24

$OLMA - Olema Pharmaceuticals, Inc.(NasdaqGS:OLMA) added to S&P Biotechnology Select Industry Index Hmm, this sounds positive... $IBRX - nicely on the front foot and $ALT looking ripe for a bounce! $XBI - Needs more love!

Hawker41 Posted - 03/19/24

$FUSN - Super congrats to the longs here, well held, yes good for $XBI (and the wider sector), reminds us Big Pharma needs to import innovation, that’s now available at some of the lowest valuations in years! I’m watching $ALT $IBRX and $OLMA #whosgonnabenext??

Paul_Volcker Posted - 4 weeks ago

$OLMA Looks ripe for a nice swing

ChicagoBull0780 Posted - 1 month ago

$RLX $RVSN $COMP $OLMA 👀👀

Paul_Volcker Posted - 1 month ago

$OLMA Why the big volume yesterday? Any ideas?

StardustTrader Posted - 1 month ago

$OLMA lol

StardustTrader Posted - 1 month ago

$OLMA wanted 10s but looks like 11s will have to do. Adding

StockInvest_us Posted - 1 month ago

Signal alert: $OLMA - Oversold Trend Short (Undervalued) https://stockinvest.us/l/1gnm3zjLjA

Hawker41 Posted - 1 month ago

$OLMA - Short interest has dropped further as suspected, now down to 4.8m shares at end of Feb, from the 6.2m reported in mid Feb… That’s still 10% of the free float! Not sure why anyone would be short this given their recent update and strong cash position. Beware the gap-risk ahead, especially when they announce details about who they’re partnering with to help facilitate and fund their Phase 3 trial.

Adamo777 Posted - 1 month ago

$OLMA why is this going down? Just buy recommendations

Thestocktraderhubzee Posted - 1 month ago

$OLMA Oppenheimer Reiterates Outperform on Olema Pharmaceuticals, Maintains $21 Price Target

DonCorleone77 Posted - 1 month ago

$OLMA Olema Oncology reports Q4 EPS (49c), consensus (48c) Reports Q4 cash, cash equivalents, and marketable securities as of December 31 were $261.8M ..."In 2023 we demonstrated the unique opportunity ahead for palazestrant to make a meaningful impact on improving treatment options for women with ER+/HER2- breast cancer. We believe palazestrant's activity on both wild-type and ESR1-mutant breast cancer, and its ability to safely combine with ribociclib, result in a highly differentiated profile amongst this emerging new class of estrogen receptor-targeting therapies," said Sean P. Bohen, M.D., Ph.D., President and Chief Executive Officer of Olema Oncology. "We have recently completed enrollment in our 60-patient Phase 2 study of 120 mg palazestrant in combination with 600 mg ribociclib, and we are looking forward to sharing an update on this study at the 2024 ESMO Breast Cancer Annual Congress....

Stock_Titan Posted - 1 month ago

$OLMA Olema Oncology Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Update https://www.stocktitan.net/news/OLMA/olema-oncology-reports-fourth-quarter-and-full-year-2023-financial-0dx4q50u23x6.html